Slide 1: Q2 2022 Financial Results
Q2 2022 Financial Results August 11, 2022 © 2022 Forian Inc. | Confidential and Proprietary 1
Slide 2: Cautionary Statement Regarding Forward-Looking Statements
Cautionary Statement Regarding Forward-Looking Statements This presentation contains “forward-looking statements” within the meaning of the federal securities laws, including Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. In this context, forwar
Slide 3: Q2 2022 Results Summary
Q2 2022 Results Summary Q2 2022 Revenue Q2 2022 Net Loss of $6.5 million of $5.4 million +44% year-over-year Q2 2022 Adjusted EBITDA1 of ($3.2) million 1 Adjusted EBITDA is a non-U.S. GAAP measure. See slide 6 and Appendix A for further information, including a reconciliation of Adjusted EBITDA to N
Slide 4: Continued Revenue Growth
Continued Revenue Growth 44% Q2 2022 revenue growth over Revenue growth driven by prior year Healthcare Information Pro-Forma Revenue illustrates revenue adjusted to include the revenue earned by Helix Technologies during the periods prior to the merger. © 2022 Forian Inc. | Confidential and Proprie
Slide 5: Revenue and Adjusted EBITDA
Revenue and Adjusted EBITDA QTR Ended June 30, (in 000's) 2022 2021 change change % Revenue $ 6,534 $ 4,548 $ 1,986 44% Net Loss $ (5,434) $ (6,965) $ 1,531 22% Adjusted EBITDA (1) $ (3,222) $ (3,638) $ 416 11% • Continued to organically grow revenue, 44% for the quarter, driven by information produ
Slide 6: Non-U.S. GAAP Reconciliations: Reported Net Income to Adjusted EBITDA
Non-U.S. GAAP Reconciliations Reported Net Income to Adjusted EBITDA $000's 2Q 2022 2Q 2021 YTD Q2 2022 YTD Q2 2021 Explanation Net Income $ (5,434) $ (6,965) $ (17,288) $ (11,481) Adjustments Depreciation & amortization 604 595 1,210 783 Stock based compensation 1,766 2,752 9,671 3,618 Change in fa
Slide 7: Summary Balance Sheet and Cash Flow
Summary Balance Sheet and Cash Flow Cash Flows Balance Sheet $000's 30-Jun-22 $000's 30-Jun-22 CASH FLOWS FROM OPERATIONS Net loss $ (17,288) Cash & marketable securities $ 23,891 Depreciation & amortization 1,210 Other current assets 5,435 PIK interest-convertible note 417 Total current assets 29,3
Slide 8: Full Year 2022 Outlook
Full Year 2022 Outlook Revenue growth of 51% to 60% resulting in total revenue in the range of $25.5 to $27 million Improvement in Adjusted EBITDA loss beginning in the second half of 2022 reaching positive Adjusted EBITDA contribution in the second half of 2023 The outlook provided above constitute
Slide 9: Q&A
Q&A © 2022 Forian Inc. | Confidential and Proprietary 9
Slide 10: Appendix A
Appendix A © 2022 Forian Inc. | Confidential and Proprietary 10
Slide 11: Reconciliation of U.S. GAAP to Non-GAAP Financial Measures
Reconciliation of U.S. GAAP to Non-GAAP Financial Measures This presentation includes a non-GAAP measure, which we define as financial information that has not been prepared in accordance with U.S. GAAP. The non-U.S. GAAP financial measure provided herein is earnings before interest, taxes, non-cash
Slide 12: © 2022 Forian Inc. | Confidential and Proprietary
© 2022 Forian Inc. | Confidential and Proprietary